idarubicinol has been researched along with Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amadori, D; Dollbaum, C; Hackett, AJ; Hiller, A; Lippman, M; Mayall, B; Smith, HS; Swain, S; Volpi, A; Zoli, W | 1 |
1 other study(ies) available for idarubicinol and Carcinoma
| Article | Year |
|---|---|
Preliminary correlations of clinical outcome with in vitro chemosensitivity of second passage human breast cancer cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Survival; Cisplatin; Daunorubicin; Doxorubicin; Epirubicin; Humans; In Vitro Techniques; Prognosis; Tumor Cells, Cultured; Vinblastine | 1990 |